293 Views | 227 Downloads
Correspondence should be addressed to Paolo Casali (pcasali@uci.edu; phone: 949-824-9648; fax: 949-824-2305).
Dr. A. Muslin (Washington University, St. Louis) and Dr. A. Wynshaw-Boris (University of California, San Francisco) for advice; I. McLeod (Scripps Research Institute) for performing MudPIT; Dr. H. Hermeking and Dr. D. Lodygin (Ludwig–Maximilians–University, Munich) for sharing preliminary data on 14-3-3σ; Dr. J. S. Hawkins and Mr. M. Crabtree for transcripts analysis; P. Patel, A. Bui and S. Yao for technical assistance; Dr. L. Yang and Dr. D. Baltimore (Caltech, Pasadena) for the pFUW lentiviral constructs and Dr. C. Murre (University of California, San Diego) for the pTAC retroviral construct; Dr. F. Byrne and Dr. R. Kurzeja (Amgen Inc.) for the purified recombinant AID; Dr. Y. Du for the purified recombinant 14-3-3 proteins; the UC Irvine Pathology Research Core Facility for immunohistochemistry.
S.-R.P. was a fellow of the Korea Research Foundation.
H. F. is a Georgia Cancer Coalition Distinguished Cancer Scholar and a Georgia Research Alliance Distinguished Investigator.
P. C. is the Donald L. Bren Professor of Medicine, Molecular Biology and Biochemistry.
H. F. was supported by the NIH grant P01 CA 116676.
J. R. Y. III was supported by the NIH grant P41 RR011823.
This work was supported by the NIH grants AI 045011, AI 079705 and AI 060573 to P.C.
© 2010 Nature America, Inc. All rights reserved.